Product Information

DULOXETINE HCL DR 30 MG CAP is a generic product labeled by American Health Packaging, priced at $0.0848 per EA under NDC 60687073401. Its NADAC has been published 150 times since May 24, 2023.

FDA first approved this application on Dec 11, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DULOXETINE HCL DR 30 MG CAP

Duloxetine Hydrochloride
$0.0848per EA
Discontinued

Strength

30 mg/1

NDC

60687073401

Classification

Generic

Dosage Form

CAPSULE, DELAYED RELEASE

Route

ORAL

Effective Date

3/18/2026

Active Ingredients

DULOXETINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA090778

FDA Approved

12/11/2013

TE Code

AB

On Market Since

4/3/2023

Pharmacological Classes

Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor

Price Statistics

The NADAC for DULOXETINE HCL DR 30 MG CAP has been published 150 times since May 24, 2023, and over the history we have for it it has declined 14.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0848 per EA
All-time high$0.1087 (Dec 13, 2023)
All-time low$0.0696 (May 22, 2024)
52-week high$0.0848
52-week low$0.0781
Median price$0.0801
Average price$0.0842
Largest weekly change-19.4% (Apr 17, 2024)
Weeks tracked150
Tracking sinceMay 24, 2023

Price History

1W

N/A

1M

N/A

3M

N/A

6M

+8.5%

1Y

+6.9%

3Y

-16.0%

5Y

N/A

All

-14.8%

Last surveyed Apr 1, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DULOXETINE HCL DR 30 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DULOXETINE HCL DR 30 MG CAP, manufactured by American Health Packaging, is $0.0848 per EA (NDC 60687073401), effective Apr 1, 2026.

How has the price of DULOXETINE HCL DR 30 MG CAP changed over time?

Over the history we have for it, the NADAC for DULOXETINE HCL DR 30 MG CAP has declined 14.8%. It has been tracked across 150 weekly CMS publications since May 24, 2023.

What are the highest and lowest recorded NADAC prices for DULOXETINE HCL DR 30 MG CAP?

Since May 24, 2023, the NADAC for DULOXETINE HCL DR 30 MG CAP has ranged from a low of $0.0696 (May 22, 2024) to a high of $0.1087 (Dec 13, 2023), with a median of $0.0801 per EA.

Are there cheaper alternatives to DULOXETINE HCL DR 30 MG CAP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DULOXETINE HCL DR 30 MG CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures DULOXETINE HCL DR 30 MG CAP?

DULOXETINE HCL DR 30 MG CAP (NDC 60687073401) is labeled by American Health Packaging, and CMS classifies it as a generic product.